Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis

Longitudinal quantitative MRI assessment of cortical damage in multiple sclerosis: A pilot study

(2017) René-Maxime Gracien et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study

(2017) Arianna Sartori et al.   JOURNAL OF NEUROLOGY

Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod

(2017) Fredrik Piehl et al.   Multiple Sclerosis Journal

“No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis

(2017) Gavin Giovannoni et al.   Multiple Sclerosis Journal

Serum neurofilament is associated with progression of brain atrophy and disability in early MS

(2017) Jens Kuhle et al.   NEUROLOGY

Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod

(2017) Fredrik Piehl et al.   Multiple Sclerosis Journal

“No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis

(2017) Gavin Giovannoni et al.   Multiple Sclerosis Journal

Long-term evolution of multiple sclerosis disability in the treatment era

(2016) et al.   ANNALS OF NEUROLOGY

The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain

(2016) Lukas Haider et al.   BRAIN

Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa

(2016) Jens Kuhle et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity

(2016) Jens Kuhle et al.   Multiple Sclerosis Journal

Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximab

(2016) Pierre de Flon et al.   NEUROLOGY

Secondary Progression in Multiple Sclerosis: Neuronal Exhaustion or Distinct Pathology?

(2016) Catherine Larochelle et al.   TRENDS IN NEUROSCIENCES

Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity

(2016) Jens Kuhle et al.   Multiple Sclerosis Journal

Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis

(2015) J. Kuhle et al.   NEUROLOGY

Disease Activity Free Status

(2014) Carolyn J. Bevan et al.   JAMA Neurology

Neurofilaments as biomarkers in multiple sclerosis

(2012) Charlotte E Teunissen et al.   Multiple Sclerosis Journal

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab

(2010) Martin Gunnarsson et al.   ANNALS OF NEUROLOGY